ORIGINAL PAPER

You have free access to this content

Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54-Week, Open-Label Study

  1. Alexander V. Murray MD1,
  2. Wolfgang Koenig MD2,
  3. Juan Garcia-Puig MD3,
  4. Samir Patel MBA, MS4,
  5. Alkaz Uddin PhD4,
  6. Jack Zhang MD, PhD4

Article first published online: 28 AUG 2012

DOI: 10.1111/j.1751-7176.2012.00706.x

Issue

The Journal of Clinical Hypertension

The Journal of Clinical Hypertension

Volume 14, Issue 12, pages 821–827, December 2012

Additional Information

How to Cite

Murray, A. V., Koenig, W., Garcia-Puig, J., Patel, S., PhD, A. U. and Zhang, J. (2012), Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54-Week, Open-Label Study. The Journal of Clinical Hypertension, 14: 821–827. doi: 10.1111/j.1751-7176.2012.00706.x

Author Information

  1. 1

    From PharmQuest, Greensboro, NC;

  2. 2

    Division of Cardiology, Department of Internal Medicine II, University of Ulm Medical Centre, Ulm, Germany;

  3. 3

    Division of Internal Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain;

  4. 4

    Novartis Pharmaceuticals Corporation, East Hanover, NJ

*Alexander V. Murray, MD, PharmQuest, 806 Green Valley Road, Suite 305, Greensboro, NC 27408 E-mail: amurray@pharmquest.biz

Publication History

  1. Issue published online: 3 DEC 2012
  2. Article first published online: 28 AUG 2012
  3. Manuscript received: March 30, 2012; revised: July 2, 2012; accepted: July 5, 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS